How to Write a Clinical Evaluation Report (CER) Under MDR
Master MDR-compliant CER writing with systematic methodology, literature review techniques, and regulatory validation strategies.
Blog
How to Build and Maintain a Quality Management System for Medical Devices
Learn essential steps to implement ISO 13485-compliant QMS for medical devices, ensuring regulatory success and patient safety.
Annex XVI Products Under MDR: What Non-Medical Devices Need to Know
Non-medical devices like cosmetic contact lenses must comply with MDR Annex XVI requirements—learn essential compliance steps.
ISO 13485 Certification: Requirements, Process and Common Pitfalls
Complete guide to ISO 13485 certification requirements, timeline, costs, and common implementation pitfalls for medical device companies.
Technical Documentation for Medical Devices: What to Include Under MDR
Master MDR technical documentation requirements with our comprehensive guide covering essential components, device classifications, and compliance strategies.
CE Marking for Medical Devices: A Step-by-Step Guide
Complete CE marking guide: classification, documentation requirements, timelines, and expert tips to avoid costly regulatory mistakes.
Drug-Device Combination Products: Regulatory Framework Explained
Master combination product regulations: FDA classification, EU pathways, and expert strategies for successful market approval.
What Is a Notified Body and How Do You Choose One?
Essential guide to notified bodies for EU medical device compliance, certification costs, and selection strategies.
ATMP Regulation in Europe: What Developers of Cell and Gene Therapies Need to Know
Master European ATMP regulations for successful cell and gene therapy development and market access.
What Are the Key Pharmaceutical Regulatory Requirements in Europe?
Master European pharmaceutical regulations: EMA processes, GMP compliance, and approval pathways for successful EU market entry.
The Drug Registration Process in Europe: Step-by-Step Explained
Navigate Europe's complex drug approval pathways with confidence. Expert insights on timelines, costs, and documentation requirements.
Biologics vs. Small Molecules: How Regulatory Requirements Differ
Discover key regulatory differences between biologics and small molecules for pharmaceutical development success.
Who needs to submit an IND application?
Learn which companies, researchers, and organizations must submit IND applications before conducting clinical trials with investigational drugs.
What Is a Marketing Authorisation Application (MAA) and How Does the Process Work?
Navigate MAA requirements for European market entry with expert regulatory guidance and proven approval strategies.
How do regulatory strategies change for combination products?
Combination products need specialized regulatory strategies due to complex multi-component oversight requirements.
What comes first, IND or NDA?
IND applications precede NDA submissions in drug development. Learn the critical timing and requirements for successful regulatory pathways.
What is the difference between a CTA and IND submission?
CTA vs IND submissions: crucial regulatory pathways that determine your clinical trial timeline, costs, and approval strategy.
What does EMA mean in clinical trials?
EMA regulates clinical trials across 27 EU member states through centralized approval processes and safety oversight systems.
